Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hospitalization | 37 | 2024 | 1290 | 5.030 |
Why?
|
Heart Failure | 16 | 2023 | 853 | 3.460 |
Why?
|
Hospitals | 16 | 2023 | 375 | 2.900 |
Why?
|
Hospital Mortality | 22 | 2024 | 841 | 2.740 |
Why?
|
Sepsis | 14 | 2021 | 272 | 2.690 |
Why?
|
Respiration, Artificial | 13 | 2021 | 292 | 2.450 |
Why?
|
Cardiac Rehabilitation | 7 | 2022 | 65 | 2.170 |
Why?
|
Patient Satisfaction | 7 | 2019 | 412 | 1.810 |
Why?
|
Critical Care | 6 | 2018 | 397 | 1.780 |
Why?
|
Disabled Persons | 5 | 2021 | 187 | 1.700 |
Why?
|
Pneumonia | 14 | 2022 | 281 | 1.650 |
Why?
|
Physicians | 7 | 2021 | 435 | 1.620 |
Why?
|
Internet | 8 | 2019 | 448 | 1.530 |
Why?
|
Aged, 80 and over | 36 | 2023 | 5128 | 1.490 |
Why?
|
Humans | 120 | 2024 | 59360 | 1.480 |
Why?
|
Accountable Care Organizations | 2 | 2023 | 60 | 1.460 |
Why?
|
Aged | 61 | 2024 | 13416 | 1.450 |
Why?
|
United States | 57 | 2024 | 7390 | 1.440 |
Why?
|
Male | 77 | 2024 | 27739 | 1.400 |
Why?
|
Retrospective Studies | 49 | 2024 | 6071 | 1.380 |
Why?
|
Health Services Accessibility | 6 | 2017 | 521 | 1.360 |
Why?
|
Female | 83 | 2024 | 30705 | 1.350 |
Why?
|
Quality Indicators, Health Care | 8 | 2018 | 332 | 1.340 |
Why?
|
Quality of Health Care | 10 | 2017 | 510 | 1.330 |
Why?
|
Neoplasms | 6 | 2023 | 1240 | 1.290 |
Why?
|
Middle Aged | 51 | 2024 | 16317 | 1.190 |
Why?
|
Medicare | 9 | 2023 | 598 | 1.170 |
Why?
|
Intensive Care Units | 6 | 2018 | 423 | 1.150 |
Why?
|
Critical Illness | 5 | 2018 | 325 | 1.110 |
Why?
|
Length of Stay | 18 | 2024 | 775 | 1.110 |
Why?
|
Hospital Costs | 7 | 2016 | 119 | 0.970 |
Why?
|
International Classification of Diseases | 3 | 2017 | 132 | 0.950 |
Why?
|
Patient Readmission | 8 | 2023 | 420 | 0.940 |
Why?
|
Patient Discharge | 6 | 2020 | 489 | 0.940 |
Why?
|
Malnutrition | 1 | 2024 | 40 | 0.880 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 10 | 2023 | 657 | 0.880 |
Why?
|
Cohort Studies | 23 | 2021 | 2374 | 0.860 |
Why?
|
Social Media | 2 | 2015 | 117 | 0.850 |
Why?
|
Patient Care | 2 | 2015 | 78 | 0.840 |
Why?
|
Antipsychotic Agents | 3 | 2016 | 292 | 0.830 |
Why?
|
Quality Improvement | 4 | 2015 | 416 | 0.810 |
Why?
|
Heart Diseases | 2 | 2022 | 206 | 0.810 |
Why?
|
Patient Acceptance of Health Care | 5 | 2019 | 450 | 0.790 |
Why?
|
Dementia | 2 | 2016 | 248 | 0.770 |
Why?
|
Attitude of Health Personnel | 5 | 2021 | 550 | 0.770 |
Why?
|
Heart Transplantation | 1 | 2023 | 162 | 0.750 |
Why?
|
Databases, Factual | 14 | 2018 | 813 | 0.710 |
Why?
|
Inpatients | 8 | 2023 | 291 | 0.700 |
Why?
|
Healthcare Disparities | 4 | 2021 | 326 | 0.690 |
Why?
|
Multiple Organ Failure | 1 | 2020 | 43 | 0.690 |
Why?
|
Personal Protective Equipment | 1 | 2020 | 29 | 0.690 |
Why?
|
Palliative Care | 2 | 2022 | 214 | 0.680 |
Why?
|
Endocarditis | 2 | 2017 | 19 | 0.680 |
Why?
|
Cross Infection | 5 | 2017 | 149 | 0.670 |
Why?
|
Rheumatoid Factor | 1 | 2019 | 12 | 0.660 |
Why?
|
Anti-Bacterial Agents | 9 | 2022 | 735 | 0.650 |
Why?
|
Empathy | 1 | 2020 | 66 | 0.650 |
Why?
|
Patient Care Team | 2 | 2020 | 326 | 0.650 |
Why?
|
Risk Assessment | 11 | 2021 | 1921 | 0.640 |
Why?
|
Potassium | 1 | 2019 | 100 | 0.630 |
Why?
|
Social Networking | 1 | 2019 | 23 | 0.630 |
Why?
|
Autoantibodies | 1 | 2019 | 172 | 0.620 |
Why?
|
Liver Cirrhosis | 3 | 2014 | 163 | 0.610 |
Why?
|
Cross-Sectional Studies | 12 | 2021 | 2373 | 0.600 |
Why?
|
Treatment Outcome | 20 | 2019 | 5284 | 0.600 |
Why?
|
Betacoronavirus | 1 | 2020 | 166 | 0.600 |
Why?
|
Adult | 30 | 2024 | 15669 | 0.580 |
Why?
|
Burnout, Professional | 1 | 2020 | 125 | 0.580 |
Why?
|
Pregnant Women | 2 | 2016 | 84 | 0.580 |
Why?
|
Hypertension | 2 | 2020 | 568 | 0.580 |
Why?
|
Logistic Models | 9 | 2021 | 1232 | 0.570 |
Why?
|
Residence Characteristics | 4 | 2017 | 215 | 0.560 |
Why?
|
Pneumonia, Bacterial | 5 | 2017 | 88 | 0.560 |
Why?
|
Terminal Care | 1 | 2018 | 96 | 0.560 |
Why?
|
Patients | 2 | 2022 | 103 | 0.560 |
Why?
|
Noninvasive Ventilation | 5 | 2021 | 70 | 0.560 |
Why?
|
Patient Admission | 5 | 2017 | 184 | 0.560 |
Why?
|
Research Report | 1 | 2017 | 26 | 0.550 |
Why?
|
Coronavirus Infections | 1 | 2020 | 192 | 0.550 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 205 | 0.550 |
Why?
|
Information Services | 1 | 2017 | 34 | 0.540 |
Why?
|
Surveys and Questionnaires | 6 | 2019 | 2513 | 0.540 |
Why?
|
Tertiary Care Centers | 1 | 2017 | 100 | 0.540 |
Why?
|
Emergency Medical Services | 1 | 2020 | 255 | 0.530 |
Why?
|
Guideline Adherence | 3 | 2017 | 290 | 0.520 |
Why?
|
Time-to-Treatment | 2 | 2020 | 98 | 0.520 |
Why?
|
Arthritis, Rheumatoid | 1 | 2019 | 322 | 0.500 |
Why?
|
Clinical Decision-Making | 1 | 2017 | 146 | 0.500 |
Why?
|
Endocarditis, Bacterial | 1 | 2016 | 31 | 0.500 |
Why?
|
Community-Acquired Infections | 6 | 2022 | 92 | 0.500 |
Why?
|
Risk Factors | 14 | 2021 | 4984 | 0.500 |
Why?
|
Mobility Limitation | 1 | 2015 | 47 | 0.490 |
Why?
|
Liver Diseases | 1 | 2017 | 138 | 0.490 |
Why?
|
Medicine in Literature | 1 | 2015 | 1 | 0.480 |
Why?
|
Medical Records Systems, Computerized | 2 | 2012 | 60 | 0.480 |
Why?
|
Quality of Life | 3 | 2023 | 1137 | 0.480 |
Why?
|
Public Policy | 1 | 2015 | 37 | 0.480 |
Why?
|
Health Services for Persons with Disabilities | 1 | 2015 | 2 | 0.480 |
Why?
|
Mortality | 1 | 2016 | 155 | 0.470 |
Why?
|
Paracentesis | 1 | 2014 | 12 | 0.470 |
Why?
|
Prenatal Care | 2 | 2016 | 169 | 0.470 |
Why?
|
Ascites | 1 | 2014 | 21 | 0.470 |
Why?
|
Decision Support Techniques | 1 | 2016 | 179 | 0.460 |
Why?
|
Respiratory Insufficiency | 4 | 2021 | 148 | 0.440 |
Why?
|
Prognosis | 5 | 2016 | 1600 | 0.430 |
Why?
|
Comorbidity | 10 | 2017 | 1078 | 0.430 |
Why?
|
Diffusion of Innovation | 1 | 2013 | 56 | 0.430 |
Why?
|
Clostridium Infections | 1 | 2014 | 45 | 0.430 |
Why?
|
Time Factors | 8 | 2021 | 3617 | 0.430 |
Why?
|
Quality Assurance, Health Care | 1 | 2015 | 251 | 0.420 |
Why?
|
Relative Value Scales | 1 | 2013 | 16 | 0.420 |
Why?
|
Age Factors | 6 | 2016 | 1504 | 0.420 |
Why?
|
Hospital Administration | 2 | 2013 | 41 | 0.410 |
Why?
|
Specialization | 1 | 2013 | 74 | 0.400 |
Why?
|
Costs and Cost Analysis | 3 | 2023 | 97 | 0.400 |
Why?
|
Echocardiography | 3 | 2023 | 457 | 0.400 |
Why?
|
Shock, Septic | 2 | 2015 | 86 | 0.380 |
Why?
|
Social Responsibility | 1 | 2011 | 11 | 0.360 |
Why?
|
Liability, Legal | 1 | 2011 | 18 | 0.360 |
Why?
|
Cost of Illness | 1 | 2012 | 156 | 0.360 |
Why?
|
Privacy | 1 | 2011 | 11 | 0.360 |
Why?
|
Disclosure | 1 | 2010 | 51 | 0.350 |
Why?
|
Social Environment | 1 | 2011 | 91 | 0.340 |
Why?
|
Information Dissemination | 1 | 2010 | 111 | 0.320 |
Why?
|
Reproducibility of Results | 5 | 2018 | 1561 | 0.320 |
Why?
|
Severity of Illness Index | 3 | 2016 | 1479 | 0.320 |
Why?
|
Waiting Lists | 2 | 2023 | 48 | 0.310 |
Why?
|
Pediatrics | 3 | 2017 | 240 | 0.310 |
Why?
|
Intubation, Intratracheal | 2 | 2021 | 194 | 0.300 |
Why?
|
Coronary Artery Bypass | 3 | 2019 | 274 | 0.290 |
Why?
|
Social Support | 1 | 2010 | 355 | 0.280 |
Why?
|
Adolescent | 15 | 2020 | 5824 | 0.270 |
Why?
|
Coronary Disease | 2 | 2018 | 244 | 0.270 |
Why?
|
Health Care Surveys | 4 | 2015 | 271 | 0.270 |
Why?
|
California | 2 | 2017 | 159 | 0.260 |
Why?
|
Poverty | 4 | 2017 | 281 | 0.260 |
Why?
|
Choice Behavior | 2 | 2017 | 78 | 0.260 |
Why?
|
Exercise Therapy | 3 | 2021 | 99 | 0.260 |
Why?
|
Pandemics | 2 | 2021 | 615 | 0.250 |
Why?
|
Minority Groups | 2 | 2017 | 135 | 0.240 |
Why?
|
Hospital Administrators | 2 | 2015 | 10 | 0.240 |
Why?
|
Access to Information | 2 | 2015 | 30 | 0.240 |
Why?
|
Sex Factors | 3 | 2012 | 935 | 0.240 |
Why?
|
Research Design | 3 | 2019 | 555 | 0.230 |
Why?
|
Patient Navigation | 2 | 2016 | 34 | 0.230 |
Why?
|
Medical Staff, Hospital | 2 | 2015 | 57 | 0.230 |
Why?
|
Heart Valve Prosthesis Implantation | 2 | 2017 | 153 | 0.230 |
Why?
|
Soft Tissue Infections | 2 | 2015 | 45 | 0.230 |
Why?
|
Attitude | 2 | 2015 | 96 | 0.230 |
Why?
|
Emergency Service, Hospital | 5 | 2020 | 1021 | 0.230 |
Why?
|
Young Adult | 11 | 2017 | 4267 | 0.230 |
Why?
|
Urinary Tract Infections | 2 | 2015 | 80 | 0.220 |
Why?
|
Hospitals, Rural | 2 | 2015 | 19 | 0.220 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2020 | 724 | 0.220 |
Why?
|
Hospitals, Urban | 2 | 2015 | 43 | 0.220 |
Why?
|
Acute Disease | 5 | 2019 | 660 | 0.220 |
Why?
|
Odds Ratio | 2 | 2016 | 745 | 0.220 |
Why?
|
Biomarkers | 2 | 2019 | 1306 | 0.220 |
Why?
|
Asthma | 3 | 2021 | 453 | 0.220 |
Why?
|
Hospitals, Teaching | 2 | 2015 | 101 | 0.220 |
Why?
|
Health Resources | 2 | 2014 | 87 | 0.220 |
Why?
|
Postoperative Complications | 3 | 2019 | 1202 | 0.210 |
Why?
|
Patient Outcome Assessment | 1 | 2023 | 52 | 0.210 |
Why?
|
Hospital Bed Capacity | 2 | 2013 | 25 | 0.200 |
Why?
|
Smoking Cessation | 2 | 2018 | 541 | 0.200 |
Why?
|
State Medicine | 2 | 2013 | 9 | 0.190 |
Why?
|
Disease Progression | 5 | 2019 | 1122 | 0.190 |
Why?
|
Prevalence | 2 | 2024 | 1252 | 0.190 |
Why?
|
Electronic Health Records | 4 | 2021 | 342 | 0.190 |
Why?
|
Insurance Claim Review | 2 | 2012 | 72 | 0.190 |
Why?
|
Exercise | 4 | 2021 | 883 | 0.190 |
Why?
|
Governing Board | 1 | 2021 | 3 | 0.190 |
Why?
|
Cardiovascular Diseases | 2 | 2019 | 788 | 0.190 |
Why?
|
Practice Patterns, Physicians' | 2 | 2018 | 687 | 0.190 |
Why?
|
Survival Analysis | 3 | 2020 | 555 | 0.180 |
Why?
|
Febrile Neutropenia | 1 | 2021 | 4 | 0.180 |
Why?
|
Cost Savings | 1 | 2021 | 52 | 0.180 |
Why?
|
Atrial Fibrillation | 2 | 2019 | 805 | 0.180 |
Why?
|
Follow-Up Studies | 4 | 2019 | 2337 | 0.180 |
Why?
|
Legionnaires' Disease | 1 | 2020 | 8 | 0.180 |
Why?
|
Health Status | 1 | 2023 | 424 | 0.180 |
Why?
|
Myocardial Infarction | 3 | 2021 | 862 | 0.180 |
Why?
|
Smokers | 2 | 2018 | 116 | 0.180 |
Why?
|
Electrocardiography | 1 | 2023 | 523 | 0.170 |
Why?
|
Predictive Value of Tests | 3 | 2021 | 1025 | 0.170 |
Why?
|
Pregnancy | 6 | 2017 | 2202 | 0.170 |
Why?
|
Cost Sharing | 1 | 2019 | 13 | 0.170 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2020 | 64 | 0.170 |
Why?
|
Exercise Test | 1 | 2021 | 242 | 0.160 |
Why?
|
Amiodarone | 1 | 2019 | 20 | 0.160 |
Why?
|
Atrial Flutter | 1 | 2019 | 21 | 0.160 |
Why?
|
Rhode Island | 1 | 2019 | 97 | 0.160 |
Why?
|
Massachusetts | 5 | 2016 | 2002 | 0.160 |
Why?
|
Socioeconomic Factors | 2 | 2012 | 741 | 0.160 |
Why?
|
Antihypertensive Agents | 1 | 2020 | 162 | 0.160 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2019 | 96 | 0.150 |
Why?
|
Infant | 7 | 2017 | 1486 | 0.150 |
Why?
|
Accidental Falls | 1 | 2019 | 124 | 0.150 |
Why?
|
Cardiology Service, Hospital | 1 | 2018 | 16 | 0.150 |
Why?
|
Data Warehousing | 1 | 2018 | 7 | 0.150 |
Why?
|
Blood Pressure | 1 | 2020 | 495 | 0.150 |
Why?
|
Patient Preference | 1 | 2018 | 78 | 0.140 |
Why?
|
Child, Preschool | 7 | 2017 | 1782 | 0.140 |
Why?
|
Health Surveys | 2 | 2023 | 298 | 0.140 |
Why?
|
Nicotine | 1 | 2018 | 113 | 0.140 |
Why?
|
Patient Compliance | 1 | 2019 | 349 | 0.140 |
Why?
|
Cancer Survivors | 1 | 2018 | 79 | 0.140 |
Why?
|
Oregon | 1 | 2017 | 19 | 0.140 |
Why?
|
Texas | 1 | 2017 | 54 | 0.140 |
Why?
|
Physician-Patient Relations | 2 | 2011 | 396 | 0.140 |
Why?
|
Evaluation Studies as Topic | 1 | 2017 | 103 | 0.140 |
Why?
|
Sample Size | 1 | 2017 | 61 | 0.140 |
Why?
|
Renal Colic | 1 | 2017 | 13 | 0.130 |
Why?
|
Administrative Claims, Healthcare | 1 | 2016 | 10 | 0.130 |
Why?
|
Cardiac Valve Annuloplasty | 1 | 2016 | 7 | 0.130 |
Why?
|
Psychotic Disorders | 2 | 2021 | 149 | 0.130 |
Why?
|
Likelihood Functions | 1 | 2016 | 68 | 0.130 |
Why?
|
Urology | 1 | 2017 | 36 | 0.130 |
Why?
|
Resuscitation Orders | 1 | 2017 | 48 | 0.130 |
Why?
|
Appointments and Schedules | 1 | 2016 | 55 | 0.130 |
Why?
|
Data Mining | 1 | 2016 | 35 | 0.130 |
Why?
|
Boston | 1 | 2017 | 246 | 0.130 |
Why?
|
Area Under Curve | 1 | 2016 | 141 | 0.130 |
Why?
|
Models, Economic | 2 | 2015 | 43 | 0.130 |
Why?
|
Child | 8 | 2019 | 4174 | 0.130 |
Why?
|
Health Facility Size | 1 | 2015 | 16 | 0.130 |
Why?
|
Fluoroquinolones | 1 | 2016 | 31 | 0.130 |
Why?
|
Hospitals, University | 1 | 2016 | 52 | 0.130 |
Why?
|
Neoplasm Metastasis | 1 | 2016 | 188 | 0.130 |
Why?
|
Diet Therapy | 1 | 2015 | 12 | 0.130 |
Why?
|
ROC Curve | 1 | 2016 | 266 | 0.120 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2017 | 114 | 0.120 |
Why?
|
Patient Care Bundles | 1 | 2015 | 11 | 0.120 |
Why?
|
Linear Models | 2 | 2017 | 402 | 0.120 |
Why?
|
Qualitative Research | 2 | 2020 | 618 | 0.120 |
Why?
|
Antineoplastic Agents | 1 | 2021 | 631 | 0.120 |
Why?
|
Incidence | 2 | 2016 | 1237 | 0.120 |
Why?
|
Heart Valve Diseases | 1 | 2016 | 88 | 0.120 |
Why?
|
Walking | 1 | 2017 | 228 | 0.120 |
Why?
|
Drug Therapy, Combination | 4 | 2020 | 452 | 0.120 |
Why?
|
Tobacco Use Disorder | 1 | 2017 | 243 | 0.120 |
Why?
|
Patient Participation | 2 | 2017 | 216 | 0.120 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2015 | 62 | 0.120 |
Why?
|
Models, Statistical | 1 | 2016 | 298 | 0.120 |
Why?
|
Physicians, Primary Care | 1 | 2015 | 72 | 0.120 |
Why?
|
Patient Transfer | 1 | 2015 | 90 | 0.120 |
Why?
|
Health Care Costs | 1 | 2016 | 203 | 0.110 |
Why?
|
Weight Loss | 1 | 2017 | 263 | 0.110 |
Why?
|
Data Collection | 2 | 2015 | 371 | 0.110 |
Why?
|
Gastroenterology | 1 | 2014 | 35 | 0.110 |
Why?
|
Ceftriaxone | 1 | 2014 | 19 | 0.110 |
Why?
|
Hospital Information Systems | 1 | 2014 | 11 | 0.110 |
Why?
|
Neuromuscular Blocking Agents | 1 | 2014 | 12 | 0.110 |
Why?
|
Macrolides | 1 | 2014 | 37 | 0.110 |
Why?
|
Mothers | 1 | 2017 | 255 | 0.110 |
Why?
|
Communication Barriers | 1 | 2014 | 56 | 0.110 |
Why?
|
Treatment Failure | 3 | 2021 | 185 | 0.110 |
Why?
|
Patient Selection | 1 | 2016 | 464 | 0.110 |
Why?
|
Drug Utilization | 1 | 2015 | 208 | 0.110 |
Why?
|
Wheelchairs | 1 | 2013 | 8 | 0.110 |
Why?
|
Architectural Accessibility | 1 | 2013 | 4 | 0.110 |
Why?
|
Moving and Lifting Patients | 1 | 2013 | 16 | 0.100 |
Why?
|
Obstetrics and Gynecology Department, Hospital | 1 | 2013 | 10 | 0.100 |
Why?
|
England | 1 | 2013 | 24 | 0.100 |
Why?
|
Hypnotics and Sedatives | 1 | 2013 | 62 | 0.100 |
Why?
|
Health Services Needs and Demand | 1 | 2014 | 203 | 0.100 |
Why?
|
Counseling | 1 | 2015 | 349 | 0.100 |
Why?
|
Delirium | 1 | 2013 | 54 | 0.100 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2013 | 60 | 0.100 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 677 | 0.100 |
Why?
|
Organ Dysfunction Scores | 1 | 2012 | 19 | 0.100 |
Why?
|
Central Venous Pressure | 1 | 2012 | 12 | 0.100 |
Why?
|
Catheterization, Swan-Ganz | 1 | 2012 | 12 | 0.100 |
Why?
|
Lung Diseases | 1 | 2013 | 170 | 0.100 |
Why?
|
Protein C | 1 | 2012 | 29 | 0.100 |
Why?
|
Clinical Coding | 1 | 2012 | 44 | 0.100 |
Why?
|
Decision Making | 2 | 2017 | 395 | 0.090 |
Why?
|
Health Status Disparities | 1 | 2013 | 137 | 0.090 |
Why?
|
Referral and Consultation | 1 | 2014 | 398 | 0.090 |
Why?
|
Chronic Disease | 1 | 2014 | 716 | 0.090 |
Why?
|
Risk Adjustment | 1 | 2011 | 93 | 0.090 |
Why?
|
Economics, Hospital | 1 | 2011 | 14 | 0.090 |
Why?
|
American Medical Association | 1 | 2011 | 6 | 0.090 |
Why?
|
Health Expenditures | 1 | 2012 | 113 | 0.090 |
Why?
|
Interviews as Topic | 1 | 2013 | 481 | 0.090 |
Why?
|
Public Sector | 1 | 2010 | 13 | 0.090 |
Why?
|
Ethics, Medical | 1 | 2011 | 37 | 0.090 |
Why?
|
United Kingdom | 1 | 2010 | 69 | 0.090 |
Why?
|
Confidentiality | 1 | 2010 | 52 | 0.090 |
Why?
|
Insurance, Health | 1 | 2011 | 133 | 0.090 |
Why?
|
Hydrocortisone | 1 | 2012 | 187 | 0.090 |
Why?
|
Advisory Committees | 1 | 2011 | 108 | 0.080 |
Why?
|
Guidelines as Topic | 1 | 2011 | 154 | 0.080 |
Why?
|
Patient Education as Topic | 1 | 2013 | 453 | 0.080 |
Why?
|
Academic Medical Centers | 1 | 2011 | 306 | 0.080 |
Why?
|
Perception | 2 | 2021 | 167 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 1 | 2017 | 1526 | 0.080 |
Why?
|
Models, Biological | 1 | 2014 | 1143 | 0.080 |
Why?
|
Communication | 1 | 2013 | 545 | 0.070 |
Why?
|
Multivariate Analysis | 3 | 2017 | 902 | 0.070 |
Why?
|
Internship and Residency | 1 | 2015 | 746 | 0.070 |
Why?
|
Hospitals, Pediatric | 2 | 2019 | 47 | 0.070 |
Why?
|
Propensity Score | 2 | 2020 | 144 | 0.070 |
Why?
|
Program Evaluation | 2 | 2017 | 470 | 0.060 |
Why?
|
Diagnosis-Related Groups | 2 | 2015 | 86 | 0.050 |
Why?
|
Legionella pneumophila | 1 | 2020 | 10 | 0.050 |
Why?
|
Staphylococcus aureus | 1 | 2022 | 169 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2023 | 263 | 0.040 |
Why?
|
Exercise Tolerance | 1 | 2020 | 75 | 0.040 |
Why?
|
Seasons | 1 | 2020 | 123 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2023 | 339 | 0.040 |
Why?
|
Symptom Flare Up | 1 | 2020 | 13 | 0.040 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 674 | 0.040 |
Why?
|
Fee-for-Service Plans | 1 | 2020 | 66 | 0.040 |
Why?
|
Preoperative Period | 1 | 2019 | 61 | 0.040 |
Why?
|
Nervous System Diseases | 1 | 2021 | 104 | 0.040 |
Why?
|
Regression Analysis | 1 | 2020 | 485 | 0.040 |
Why?
|
Income | 1 | 2019 | 156 | 0.040 |
Why?
|
Social Class | 1 | 2019 | 122 | 0.040 |
Why?
|
American Hospital Association | 1 | 2017 | 3 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2023 | 582 | 0.040 |
Why?
|
Observation | 1 | 2017 | 29 | 0.030 |
Why?
|
Insurance | 1 | 2017 | 16 | 0.030 |
Why?
|
Kidney Calculi | 1 | 2017 | 17 | 0.030 |
Why?
|
Nephrology | 1 | 2017 | 15 | 0.030 |
Why?
|
Healthy Volunteers | 1 | 2017 | 66 | 0.030 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2017 | 41 | 0.030 |
Why?
|
Cardiotonic Agents | 1 | 2016 | 50 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2016 | 136 | 0.030 |
Why?
|
Diuretics | 1 | 2016 | 59 | 0.030 |
Why?
|
Vasodilator Agents | 1 | 2016 | 63 | 0.030 |
Why?
|
Emergencies | 1 | 2016 | 111 | 0.030 |
Why?
|
Administration, Intravenous | 1 | 2016 | 61 | 0.030 |
Why?
|
Erythrocyte Transfusion | 1 | 2016 | 72 | 0.030 |
Why?
|
Vulnerable Populations | 1 | 2016 | 84 | 0.030 |
Why?
|
Cost Control | 1 | 2015 | 24 | 0.030 |
Why?
|
Administration, Oral | 1 | 2016 | 356 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2023 | 1118 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2016 | 169 | 0.030 |
Why?
|
Bronchodilator Agents | 1 | 2015 | 122 | 0.030 |
Why?
|
Kidney Failure, Chronic | 1 | 2016 | 206 | 0.030 |
Why?
|
Ultrasonography | 1 | 2017 | 459 | 0.030 |
Why?
|
Emergency Medicine | 1 | 2017 | 181 | 0.030 |
Why?
|
Program Development | 1 | 2015 | 203 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2015 | 179 | 0.030 |
Why?
|
Percutaneous Coronary Intervention | 1 | 2016 | 160 | 0.030 |
Why?
|
Bacteremia | 1 | 2015 | 91 | 0.030 |
Why?
|
Continuity of Patient Care | 1 | 2015 | 170 | 0.030 |
Why?
|
Substance-Related Disorders | 1 | 2021 | 682 | 0.030 |
Why?
|
Pamphlets | 1 | 2013 | 17 | 0.030 |
Why?
|
Urban Health Services | 1 | 2013 | 14 | 0.030 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 442 | 0.030 |
Why?
|
Patient Safety | 1 | 2015 | 237 | 0.030 |
Why?
|
Child Health Services | 1 | 2013 | 61 | 0.030 |
Why?
|
Health Literacy | 1 | 2013 | 78 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2015 | 273 | 0.020 |
Why?
|
Comprehension | 1 | 2013 | 131 | 0.020 |
Why?
|
Stroke | 1 | 2021 | 1127 | 0.020 |
Why?
|
Population Surveillance | 1 | 2013 | 194 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2015 | 515 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2013 | 1283 | 0.020 |
Why?
|
Prospective Studies | 1 | 2014 | 3067 | 0.020 |
Why?
|